Main clinical and pathological characteristics of study population
| Characteristics | Median (fifth; ninth)/n (%) | |
| Age, years | 42.0 (28.0; 71.0) | |
| Body mass index | 24.8 (18.6; 35.0) | |
| FIGO staging 2018 | IA1 | 13 (3.3%) |
| IA2 | 15 (3.8%) | |
| IB1 | 86 (22.1%) | |
| IB2 | 125 (32.1%) | |
| IB3 | 38 (9.7%) | |
| IIA1 | 4 (1.0%) | |
| IIA2 | 1 (0.3%) | |
| IIB | 29 (7.4%) | |
| IIIA | 0 (0.0%) | |
| IIIB | 1 (0.3%) | |
| IIIC1 | 56 (14.4%) | |
| IIIC2 | 19 (4.8%) | |
| IVA | 2 (0.5%) | |
| IVB | 1 (0.3%) | |
| Histological type | Squamous cell carcinoma | 292 (74.9%) |
| Adenocarcinoma | 81 (20.8%) | |
| Adenosquamous carcinoma | 8 (2.1%) | |
| Neuroendocrine carcinoma | 9 (2.3%) | |
| Tumor diameter* | < 20 mm | 119 (30.5%) |
| 20–39 mm | 160 (41.0%) | |
| ≥ 40 mm | 111 (28.5%) | |
| Grade | 1 | 48 (12.3%) |
| 2 | 165 (42.3%) | |
| 3 | 177 (45.4%) | |
| LVSI | No | 186 (47.7%) |
| Yes | 184 (47.2%) | |
| Unknown | 20 (5.1%) | |
*Based on the pathological assessment or ultrasonography assessment if surgery of cervical tumor not performed.
FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion.